Pfizer, Inc. | Pfizer | kickbacks and bribery | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
Pfizer, Inc. | Pfizer | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
Pfizer, Inc. | Pfizer | environmental violation | 2010 | CT-ENV | $31,266 |
Pfizer, Inc. | Pfizer | consumer protection violation | 2022 | KS-AG | $85,000 |
PFIZER, INC. | Pfizer | workplace safety or health violation | 2009 | OSHA | $7,155 |
PFIZER, INC. | Pfizer | workplace safety or health violation | 2012 | OSHA | $9,600 |
Pfizer Pharmaceuticals, LLC | Pfizer | environmental violation | 2016 | EPA | $190,000 |
Pfizer Pharmaceuticals, LLC | Pfizer | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $728,000 |
Pfizer Pharmaceuticals Ltd. | Pfizer | environmental violation | 2004 | EPA | $20,025 |
Pfizer Pharmaceuticals LLC | Pfizer | environmental violation | 2014 | EPA | $728,000 |
Pfizer Pharmaceuticals LLC | Pfizer | environmental violation | 2005 | EPA | $55,000 |
Pfizer Pharmaceuticals | Pfizer | environmental violation | 2010 | EPA | $24,650 |
Pfizer Inc. and Pharmacia Corp. | Pfizer | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
Pfizer Inc. | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $26,339,944 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
Pfizer Inc. | Pfizer | environmental violation | 2008 | EPA | $975,000 |
Pfizer Inc. | Pfizer | railroad safety violation | 2002 | FRA | $11,250 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,621,154 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $60,000,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | MA-AG | $375,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $42,900,000 |
Pfizer Inc. | Pfizer | consumer protection violation | 2018 | NY-AG | $700,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2019 | IL-AG | $41,047,101 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
Pfizer Inc. | Pfizer | environmental violation | 2012 | CA-DPR | $6,720 |
Pfizer Inc. | Pfizer | environmental violation | 2006 | CT-ENV | $40,224 |
Pfizer Inc. | Pfizer | consumer protection violation | 2022 | KS-AG | $85,564 |
Pfizer Inc. | Pfizer | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $190,000,000 |
Pfizer Inc. | Pfizer | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $94,000,000 |
Pfizer Inc. | Pfizer | price-fixing or anti-competitive practices | 2021 | private lawsuit-federal | $345,000,000 |
Pfizer Inc. | Pfizer | employment discrimination | 2023 | OFCCP | $2,500,000 |
PFIZER INC / GROTON SITE | Pfizer | environmental violation | 2005 | EPA | $22,500 |
Pfizer H.C.P. Corporation | Pfizer | Foreign Corrupt Practices Act | 2012 | DOJ_CRIMINAL | $15,000,000 |
PFIZER GLOBAL MANUFACTURING | Pfizer | environmental violation | 2008 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $975,000 |
Pfizer Corporation | Pfizer | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
Pfizer | Pfizer | employment discrimination | 2009 | private lawsuit-federal | $1,365,003 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
Pfizer | Pfizer | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $35,000,000 |
Pfizer | Pfizer | consumer protection violation | 2019 | OR-AG | $975,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $288,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $745,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2004 | private lawsuit-federal | $750,000,000 |
Pfizer | Pfizer | consumer protection violation | 2022 | CO-AG | $137,174 |
Pfizer | Pfizer | consumer protection violation | 2022 | VT-AG | $34,564 |
Pfizer | Pfizer | consumer protection violation | 2022 | AZ-AG | $124,527 |
PERRIGO COMPANY PLC | Perrigo | workplace safety or health violation | 2023 | OSHA | $12,600 |
PERRIGO COMPANY OF SOUTH CAROLINA | Perrigo | workplace safety or health violation | 2008 | OSHA | $5,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | FTC | $3,750,000 |
Perrigo Company | Perrigo | Family and Medical Leave Act | 2014 | WHD | $15,022 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
Perrigo Company | Perrigo | employment discrimination | 2021 | NY-NYCCHR | $20,000 |
Perrigo Co. | Perrigo | consumer protection violation | 2022 | CA-MULTI | $360,000 |
Perrigo | Perrigo | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
PERNIX THERAPEUTICS, LLC | Currax Pharmaceuticals | benefit plan administrator violation | 2019 | EBSA | $10,001 |
Pernix Therapeutics, LLC | Currax Pharmaceuticals | WARN Act violation | 2019 | private lawsuit-federal | $300,000 |
Pernix Therapeutics | Currax Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
PBM NUTRITIONALS LLC | Perrigo | workplace safety or health violation | 2021 | OSHA | $14,502 |
Parexel International, LLC | Parexel International | labor relations violation | 2012 | NLRB | $253,000 |
Par Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
Par Pharmaceutical, Inc. | Endo International | False Claims Act and related | 2010 | MA-AG | $500,000 |
Par Pharmaceutical Inc. | Endo International | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Par Pharmaceutical Cos., Inc. | Endo International | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
Par Pharmaceutical Co. | Endo International | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Pacira Pharmaceuticals Inc. | Pacira BioSciences | False Claims Act and related | 2020 | USAO | $3,500,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | FDA | $4,000,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $12,500 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $5,070 |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | consumer protection violation | 2007 | VT-AG | $10,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $67,000,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Organon USA Inc. | Organon & Co. | drug or medical equipment safety violation | 2018 | private lawsuit-federal | $100,000,000 |
Organon USA Inc | Organon & Co. | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $36,000,000 |
Organon Inc. | Organon & Co. | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
Organon | Organon & Co. | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $31,000,000 |
Omeros Corporation | Omeros Corp. | False Claims Act and related | 2012 | private lawsuit-federal | $3,940,000 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | workplace safety or health violation | 2003 | OSHA | $5,610 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | environmental violation | 2016 | EPA | $8,400 |
NOVOZYMES BIOLOGICALS, INC | Novo Holdings A/S | environmental violation | 2009 | EPA | $26,797 |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | environmental violation | 2009 | NC-ENV | $36,836 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | FDA | $25,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | DOJ_CIVIL | $58,650,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2011 | USAO | $1,725,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2017 | CA-INS | $1,100,000 |